Growth Metrics

Merck (MRK) Property, Plant & Equipment (Net) (QoQ) (2009 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 0.46%
Dec 31, 2025 -1.26%
Sep 30, 2025 1.60%
Jun 30, 2025 3,224.90%
Mar 31, 2025 -96.81%
Dec 31, 2024 1.42%
Sep 30, 2024 0.97%
Jun 30, 2024 0.76%
Mar 31, 2024 -0.03%
Dec 31, 2023 2.33%
Sep 30, 2023 1.33%
Jun 30, 2023 2.17%
Mar 31, 2023 1.57%
Dec 31, 2022 4.89%
Sep 30, 2022 1.82%
Jun 30, 2022 1.58%
Mar 31, 2022 2.43%
Dec 31, 2021 3.85%
Sep 30, 2021 2.77%
Jun 30, 2021 -1.26%
Mar 31, 2021 7.62%
Dec 31, 2020 0.48%
Sep 30, 2020 7.16%
Jun 30, 2020 3.41%
Mar 31, 2020 6.80%
Dec 31, 2019 0.07%
Sep 30, 2019 3.07%
Jun 30, 2019 2.64%
Mar 31, 2019 1.62%
Dec 31, 2018 4.20%
Sep 30, 2018 1.02%
Jun 30, 2018 0.52%
Mar 31, 2018 0.98%
Dec 31, 2017 2.05%
Sep 30, 2017 0.79%
Jun 30, 2017 0.43%
Mar 31, 2017 0.13%
Dec 31, 2016 -0.02%
Sep 30, 2016 0.35%
Jun 30, 2016 -3.02%
Mar 31, 2016 -1.18%
Dec 31, 2015 0.20%
Sep 30, 2015 -1.17%
Jun 30, 2015 -2.17%
Mar 31, 2015 -1.72%
Dec 31, 2014 -2.25%
Sep 30, 2014 -3.28%
Jun 30, 2014 -2.82%
Mar 31, 2014 -4.52%
Dec 31, 2013 -2.28%
Sep 30, 2013 -2.30%
Jun 30, 2012 -1.59%
Mar 31, 2012 -1.06%
Dec 31, 2011 -0.52%
Sep 30, 2011 -1.73%
Jun 30, 2011 -0.96%
Mar 31, 2011 -1.46%
Dec 31, 2010 -0.20%
Sep 30, 2010 -1.26%
Jun 30, 2010 -3.62%
Mar 31, 2010 -1.61%
Dec 31, 2009 163.99%
Sep 30, 2009 0.74%